妓院一钑片免看黄大片,亚洲av无码成人精品国产,亚洲AV综合色区无码专区桃色,免费A级毛片在线播放不收费

三石風(fēng)險投資 Third Rock Ventures  
Third Rock Ventures是一家成立于2007年的醫(yī)療健康領(lǐng)域風(fēng)險投資公司，總部在波士頓和三藩，募集基金高達(dá)13億美金。到現(xiàn)在為止，Third Rock投資給31家生物醫(yī)療公司。其中5家從事的是癌癥治療相關(guān)的業(yè)務(wù)。

Third Rock Ventures was founded in 2007 with the mission to launch transforming companies. We set out to build a different firm – a firm that was squarely focused on launching exceptional healthcare companies with passionate entrepreneurs, working in areas of disruptive science and medicine to make a difference in the lives of patients.

We are not just launching new healthcare companies - we are rapidly growing them, advancing pipelines to the clinic and developing new products. In just six short years, and during a period of time when early stage investing has been in flux, we have successfully raised more than $1.3 billion and invested in more than 31 companies to accomplish this mission. We truly believe that nothing is impossible.

We take investments in our companies and our people seriously, as we strive to be the best business partners in the world. By working closely with the scientific and business communities, we seek to identify the most promising opportunities for the future of medicine and then build the team and company structure to make this visionary science a business reality. Our portfolio companies are formed around disruptive areas of science and medicine and the convergence of technology and genomics, and many have been developed as part of collaborations with big pharma and big biotech. Collaborative company building is the future, and Third Rock and its portfolio companies are at the forefront of this paradigm shift with early-stage yet highly valued strategic partnerships.

Our approach is bold, our thinking is outside-of-the-box and we apply the same innovative spirit to our deal-making as we do to our companies' science. Together, this approach is designed to achieve our ultimate goal – launching and building transforming companies that make a difference for patients through breakthroughs in medicine.